Analystreport

Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA) was downgraded by analysts at BidaskClub from a "strong-buy" rating to a "buy" rating.

MOMENTA PHARMACEUTICALS  (MNTA) 
Last momenta pharmaceuticals earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.momentapharma.com/investor-relations